doi: 10.3390/nu13020598 151 FernandesSPMaChadoMBSantosZEANogueira-de-AlmeidaCAde MelloED
Its main actions include: Stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner Suppressing glucagon release, which reduces hepatic glucose production Slowing gastric emptying, which moderates post-meal glucose spikes Promoting satiety through central nervous system pathways, thereby reducing appetite GIP is released by K-cells in the proximal small intestine and shares some functions with GLP-1, particularly in enhancing insulin secretion after meals
106 GLP-1 is also generated similarly in the central nervous system
As these become available, the principles in this guide, understanding half-life, aligning peak effects with needs, managing side effect windows, will still apply
These symptoms are not something to ignore
Q8: What can peptide therapy help with